Skip to content

Recent Additions in the Treatment of Depressive Disorders

Live Online Webinar
Friday, December 4, 2020 | 2:00 PM - 3:00 PM EST

This activity is designed to meet the educational needs of healthcare professionals who assist in prescribing and monitoring medication therapy for the treatment of depression.

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Summarize the safety and efficacy of the recently approved agents for major depressive disorder, treatment-refractory depression, and post-partum depression.
  • Identify the appropriate patients who will benefit from these new therapies,
  • Recognize the expected impact of these newly approved antidepressants in the standard course of treatment for major depressive disorder, treatment-refractory depression, and post-partum depression


Michael Angelini, BA, BS, MA, PharmD, BCPP, RPh
Michael Angelini, BA, BS, MA, PharmD, BCPP, RPh is a Professor of Pharmacy Practice at MCPHS University in Boston, Massachusetts, and a Psychiatric Clinical Pharmacist at Saint Luke’s Hospital in New Bedford, MA. He is also a Psychopharmacology Consultant for Commonwealth Pharmacy Services at the University of Massachusetts Medical School. Additionally, he has been a clinical consultant to primary care, community health centers, and group homes throughout New England. He has served on faculty positions in the Addiction Fellowship Program at Boston University School of Medicine, the Massachusetts School of Professional Psychology, and Harvard Medical School. Dr. Angelini earned his Master’s degree in Clinical Psychology at Boston University and his Doctor of Pharmacy degree at MCPHS University. Board-certified in Psychiatric Pharmacy, Dr. Angelini has published chapters in therapeutics textbooks, study guides, and articles in peer-reviewed journals. Dr. Angelini is a member of the American Association of Colleges of Pharmacy and the Massachusetts Pharmacists Association.

Registration is required if you would like to earn ACPE credit for attending. There is no fee to participate.


ACPE logo



MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

Partial credit will not be awarded. To claim credit participants must log into their profile on MCPHS CE portal and insert the specific activity code for this webinar in order to access and complete the evaluation. CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours.

Attendance will be verified. Credit will not be issued to participants who join the meeting more than 15 minutes after the start of the meeting or to those who depart early. Credit cannot be awarded to individuals who complete the activity evaluation more than 60 days post activity.


All participants will have the opportunity to review the educational session and speakers, and to identify future educational needs.

Statement of Disclosure

MCPHS University adheres to the ACPE Standards regarding commercial support of continuing pharmacy education. It is the policy of MCPHS University that the speakers and planning committee disclose real or apparent conflicts of interest relating to the topics of the educational activity, that relevant conflicts of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

Michael Angelini, BA, BS, MA, PharmD, BCPP, RPh has no relevant financial relationships to disclose.
No funding from industry provided for this event. No exhibitors will be present.
All CE staff members have no relevant financial relationships to disclose.